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Abstract: Laboratory tests are frequently ordered by general practitioners (GPs), but little is known 
about time trends and between-GP variation of their use. In this retrospective longitudinal study, 
we analyzed over six million consultations by Swiss GPs during the decade 2009–2018. For 15 
commonly used test types, we defined specific laboratory testing rates (sLTR) as the percentage of 
consultations involving corresponding laboratory testing requests. Patient age- and sex-adjusted 
time trends of sLTR were modeled with mixed-effect logistic regression accounting for clustering of 
patients within GPs. We quantified between-GP variation by means of intraclass correlation 
coefficients (ICC). Nine out of the 15 laboratory test types considered showed significant temporal 
increases, most eminently vitamin D (ten-year odds ratio (OR) 1.88, 95% confidence interval (CI) 
1.71–2.06) and glycated hemoglobin (ten-year OR 1.87, 95% CI 1.82–1.92). Test types both subject to 
substantial increase and high between-GP variation of sLTR were vitamin D (ICC 0.075), glycated 
hemoglobin (ICC 0.101), C-reactive protein (ICC 0.202), and vitamin B12 (ICC 0.166). Increasing 
testing frequencies and large between-GP variation of specific test type use pointed at 
inconsistencies of medical practice and potential overuse. 




Laboratory testing is one of the most frequently used diagnostic modalities in health care and 
influences up to 70% of all critical decisions [1]. During the past 20 years, the number of laboratory 
test types available for clinicians has doubled, and several studies have described an increase in the 
number of laboratory tests ordered in general practice [2–6]. The necessity of this increase in testing 
has been questioned, as healthcare systems are generally facing growing overuse of all kinds of 
diagnostic tests, also in primary care [7]. Furthermore, inappropriate testing might be detrimental to 
patients, causing psychological and physical harm as well as unnecessary financial burden [8].  
Ideally, the use of laboratory tests should depend exclusively on patient factors that determine 
a clear indication. However, physician factors are also associated with the decision to order 
laboratory tests [9,10]. Physician sex [2], working environment [2], time since medical school 
graduation [11], tolerance of diagnostic uncertainty, and time pressure [9] have been found to be 
associated with test-ordering behavior. Some physicians assume that routine laboratory testing saves 
time, increases patient satisfaction and reassurance, and reduces the risk of malpractice liability [9,12]. 
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In addition, fee-for-service billing in healthcare might contribute to overuse of laboratory testing by 
adding a financial incentive to increase quantity of testing [13]. In Swiss general practice, the 
availability of laboratory tests is high since their majority is reimbursed by mandatory health 
insurance and most general practitioners (GPs) maintain own facilities for point-of-care testing [14]. 
A subset of laboratory tests consists of reimbursable point-of-care tests, which poses additional direct 
financial incentives for getting the most of such on-site testing facilities [15]. Moreover, laboratory 
tests are a supply-sensitive element of care, meaning that increased availability may lead to overuse 
[16].  
Even though the majority of laboratory tests in Switzerland are ordered in general practice [17], 
requesting patterns among GPs have not been the subject of recent research. With our study, we 
aimed to address this gap by describing trends and between-physician variation of laboratory testing 
in Swiss general practice. 
2. Experimental Section 
2.1. Study Design, Setting, and Participants 
This study is a retrospective longitudinal database analysis in Swiss general practice using data 
from the Family Medicine ICPC (International Classification of Primary Care) Research using 
Electronic Medical Records (FIRE) project, which comprises of a network of GPs in German-speaking 
Switzerland exporting anonymized routine data from their electronic medical records to a central 
database. Among other information such as demographic patient characteristics, ICPC diagnostic 
codes, and drug prescriptions, GPs also contribute laboratory testing requests. We assessed data over 
one decade, ranging from the initiation of the FIRE project on 1 January 2009 to 31 December 2018. 
During this period, 389 GPs exported information on more than 6 million consultations of over 
570,000 individual patients. 
The local ethics committee of the canton of Zurich waived approval, as the project lay outside 
the scope of the Federal Act on Research involving Human Beings (BASEC-Nr. Req-2017-00797) [18]. 
2.2. Data Preparation and Selection 
We validated laboratory test data by checking all exported labels, units, and distributions of test 
results for plausibility as well as for database errors (e.g., double counting because of multiple exports). 
The test panels complete blood count (CBC), urinalysis, liver enzymes, lipid profile, and electrolytes 
(sodium, chloride and potassium) were aggregated and considered as single tests. We approached data 
from all GPs in the FIRE project who exported at least 1000 consultations over the study period. 
Exclusion criteria were defined for the elimination of rare test types to increase the relevance of results 
and ensure sample sizes were sufficient for meaningful trend analyses and comparisons. Specifically, 
we excluded test types requested by less than 10% of all GPs over the observation period or requested 
by less than 10 GPs during any specific year. In addition, we excluded test types occurring with an 
among-GP median request rate below 1% of consultations over the study period. For each consultation, 
we extracted date, presence and type of laboratory test requests, (anonymized) IDs of patients and GPs 
as well as patient age and sex. Depending on the medical record software, some test types had not been 
exported by all GPs since their registration in the FIRE project, but export was enabled later during the 
study period after software updates. To assess testing behavior and frequencies, we therefore defined 
GP-specific observation starting points for counting both consultations and laboratory requests to fit 
the dates after which GPs actually started exporting respective test types. 
2.3. Objectives 
We aimed to determine GPs’ test type-specific usage frequencies of selected laboratory tests in 
terms of requesting rates per consultation and defined specific laboratory testing rates (sLTR) as the 
percentage of consultations by one single GP in which a specific laboratory test type was requested. 
Analyses of sLTR comprised of assessment of among-GP distribution, time trends, association with 
patients’ demographic factors, and measures of between-GP variation by extraction of the sLTR 
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variance component attributable to within-GP clustering. For investigation of general testing 
variability and general association of testing with patient demographic factors, an overall laboratory 
testing rate (oLTR) was defined as the percentage of consultations in which at least one of the specific 
test types ultimately included in our analysis was requested. 
2.4. Statistical Analysis 
We approached sLTR analysis on the level of single consultations by definition of test type-specific 
binary variables denoting whether that particular laboratory test type was requested during a 
consultation. For oLTR, in an analogous manner, we introduced a binary variable encoding request 
during a consultation of at least one of the test types considered. For each test type separately, mixed-
effect logistic regression was used to model the annual time trend with adjustment for patient sex and 
age (in years) as fixed factors. Random intercepts on the GP- and patient-level were introduced to 
account for repeated observations and clustering of patients within GPs. We determined odds ratios 
(OR) and corresponding 95% confidence intervals (95% CI) to report the effect of fixed factors on sLTR. 
Null models including time as the only fixed factor, but using the same random factor structure, 
provided a way to quantify the proportion of sLTR variance attributable to between-GP factors by 
assessing the corresponding intraclass correlation coefficients (ICC). 
For analysis of oLTR, we fitted a mixed-effect model with hierarchical random intercepts on the 
GP- and patient-level with adjustments for patient age and sex as fixed factors to our data. A null 
random intercept-only model was used for computation of the GP-level ICC. As an additional measure 
of oLTR variation, we computed the central 90% range of GP-level OR for overall testing from the 
central 90% range of the GP-level random effect distribution as predicted by the null regression model. 
This quantity can be interpreted as the OR for requesting any laboratory test during a consultation of a 
given patient between a GP of relatively high oLTR (95th percentile) and a GP of relatively low oLTR 
(5th percentile) as predicted by the regression model. 
We used R 3.6.3 (R Foundation for Statistical Computing, Vienna, Austria) for data cleaning and 
statistical analyses with the library lme4 for mixed-effect model fitting [19,20]. We reported statistical 
significance in terms of p-values using a significance threshold of 0.05. 
3. Results 
3.1. Selection Process 
During the observation period (1 January 2009–31 December 2018), we approached 91 test types 
(n = 3,840,762 requests) out of which 21 were excluded (n = 53,879 or 1.4% of all requests) as they were 
requested by less than 10% of all GPs over the observation period or by less than 10 GPs during one 
specific year. Additionally, 54 test types (n = 338,362 or 8.8% of all requests) were excluded for 
occurring with an among-GP median sLTR below 1% of consultations. To enable meaningful time 
trend assessment, only test types present for at least five years in the database were considered, 
leading to exclusion of one test type (n = 8926 or 0.2% of all requests). In total, 6,116,587 consultations 
from 574,803 patients (52% female, median age at first consultation 44 years, interquartile range (IQR) 
28–61 years) were analyzed after the exclusion of 221 patients (0.04% of total) due to missing 
information about age and/or sex (see Table 1 for characteristics of included patients). The 15 test 
types finally included (n = 3,435,297 or 89.4% of all requests) originated from 389 GPs working in 164 
practices. Patients were followed over a median of 206 days (IQR 1–703 days) and were observed in 
a median number of four consultations (IQR 1–11 consultations). Supplementary Figure S1 
summarizes the data selection process.
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Table 1. Characteristics of patients included for analysis. 
Characteristic 
At Least One Laboratory Test 
Reported 
(n = 315,807) 
No Laboratory Tests 
Reported 
(n = 258,996) 
Male sex, n (%) 172,810 (54.7) 132,062 (51.0) 
Female sex, n (%) 142,997 (45.3) 126,934 (49.0) 
Median age at observation start, years 
(IQR) 48 (32–64) 39 (25–56) 
Median follow-up time, days (IQR) 406 (134–1152) 8 (1–227) 
Median consultations per patient, n 
(IQR) 
9 (1–19) 2 (1–4) 
Abbreviations: IQR, interquartile range. 
3.2. Test Type-Specific Use of Laboratory Tests 
Crude among-GP distributions of sLTR before age and sex adjustment are visualized in Figure 
1 and Figure 2 (overall and annual distributions, respectively) for the 15 test types addressed 
(distributions for the test types excluded from analysis can be found in Supplementary Figure S2). 
The top three most frequently requested test types among GPs over the study period (Figure 1 and 
Figure 2) were complete blood count (among-GP median sLTR 15.1%, IQR 11.5–18.5%), C-reactive 
protein (CRP; among-GP median sLTR 10.4%, IQR 6.8–14.4%) and serum creatinine (among-GP 
median 7.2%, IQR 5.3–9.1%). 
  
Figure 1. Crude among-general practitioner (GP) distributions of 2009–2018 average specific 
laboratory testing rates. Test types were included according to the criteria described in the main text. 
Type-specific laboratory testing rates were calculated for each GP as the percentage of consultations 
during the GP’s observation period involving a request of the respective test type. Abbreviations: 
CBC, complete blood count; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; HbA1c, 
glycated hemoglobin; PT/INR, prothrombin time/international normalized ratio; TSH, thyroid-
stimulating hormone. 
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Figure 2. Crude among-general practitioner (GP) distributions of annual average specific laboratory 
testing rates for the years 2009–2018. Test types were included according to the criteria described in 
the main text. Outliers are omitted for better readability. Abbreviations: CBC, complete blood count; 
CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; HbA1c, glycated hemoglobin; PT/INR, 
prothrombin time/international normalized ratio; TSH, thyroid-stimulating hormone. 
Test type-specific mixed-effect regression results are displayed graphically in Figure 3 (time 
trends in panel (a), associations with patient age in panel (b), associations with patient sex in panel 
(c), and GP-level ICCs in panel (d)). Numerical results can be found in the Supplementary Tables S1–
S15. Of the 15 test types considered, nine showed a significant increase, four a significant decrease 
and two no significant time trend in terms of age- and sex-adjusted ten-year OR. We found the 
strongest increases for vitamin D (ten-year OR 1.88, 95% CI 1.71–2.06) and glycated hemoglobin 
(HbA1c; ten-year OR 1.87, 95% CI 1.82–1.92), and the strongest decreases for prothrombin 
time/international normalized ratio (PT/INR; ten-year OR 0.33, 95% CI 0.31–0.35) and erythrocyte 
sedimentation rate (ESR; ten-year OR 0.63, 95% CI 0.61–0.65). 
  
(a) (b) 




Figure 3. Results of mixed-effect regression analysis for specific laboratory testing rates. (a) Ten-year 
time trends. (b) Effect sizes of patient age. (c) Effect sizes of patient sex. (d) Between-general 
practitioner variance in terms of the null-model intraclass correlation coefficient. Abbreviations: CBC, 
complete blood count; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; HbA1c, glycated 
hemoglobin; PT/INR, prothrombin time/international normalized ratio; TSH, thyroid-stimulating 
hormone. 
Of the 15 test types analyzed, 12 were requested more frequently for increasing patient age, with 
the strongest effect for PT/INR (ten-year OR 1.49, 95% CI 1.47–1.52) and electrolytes (ten-year OR 
1.30, 95% CI 1.30–1.31). On the other side, ferritin (ten-year OR 0.91, 95% CI 0.91–0.92), CRP (ten-year 
OR 0.94, 95% CI 0.93–0.94) and CBC (ten-year OR 0.99, 95% CI 0.98–0.99) were the only test types 
showing an increase of sLTR for decreasing patient age. Requesting of 14 test types was associated 
with patient sex. The strongest association with male sex was seen for lipid profile (male-to-female 
OR 1.61, 95% CI 1.58–1.64) and PT/INR (male-to-female OR 1.46, 95% CI 1.37–1.55), while the test 
types with strongest female sex association were ferritin (male-to-female OR 0.40, 95% CI 0.40–0.41) 
and vitamin D (male-to-female OR 0.54, 95% CI 0.52–0.55). 
Concerning between-GP variation, we found the highest GP-level ICC for fasting glucose (0.231), 
CRP (0.202), and vitamin B12 (0.166), and the lowest for PT/INR (0.000), ferritin (0.018), and lipid 
profile (0.044). 
3.3. Overall Use of Laboratory Tests 
Non-adjusted among-GP median oLTR was 20.2% (IQR 16.9–24.0%) over the study period. In 
mixed-effect analysis, male patients were found to be tested less frequently than female patients 
(male-to-female OR 0.87, 95% CI 0.86–0.88), while increasing patient age was associated with higher 
oLTR (ten-year age OR 1.060, 95% CI 1.056–1.065). The GP-level ICC was obtained as 0.032, the central 
90% GP-level OR range as 4.2 (5th log OR percentile −0.54, 95th log OR percentile 0.90). Figure 4 
shows the distribution of GP-level random effect estimates. 
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Figure 4. General practitioner-level random effect distribution. Each single point indicates the patient 
age- and sex-adjusted random effect estimate for one general practitioner (GP; n = 389) for the overall 
laboratory testing rate. Such a random effect estimate is numerically equivalent to the estimated log 
OR for laboratory testing during a consultation of a given patient by the corresponding GP relative to 
a rate given by the fixed intercept estimate of the null model (Table 2). The difference between the x-
coordinates of any two point estimates can therefore be interpreted as the log OR between the 
corresponding GPs for laboratory testing during a consultation of a given patient. 
Table 2. Results of mixed-effect logistic regression analysis for overall laboratory testing. 
Full Model 
Consultations, n 1,608,613    
Fixed effects β (SE) OR (95% CI) Wald’s χ2 p-Value 
Intercept −1.95 (0.03) 0.14 (0.13–0.15) −60 <0.001 
Male sex −0.143 (0.009) 0.87 (0.86–0.88) −16 <0.001 
Age (10 years) 0.058 (0.002) 1.060 (1.056–1.065) 27 <0.001 
Random effects Variance estimate Group members, n   
Patient ID 3.16 234,931   
GP ID 0.22 210   
Null model 
Fixed effects β (SE) OR (95% CI) Wald’s χ2 p-Value 
Intercept −2.04 (0.03) 0.13 (0.12–0.14) −72 <0.001 
Random effects Variance estimate ICC   
Patient ID 3.17    
GP ID 0.21 0.032   
Abbreviations: β, coefficient estimate; SE, standard error; OR, odds ratio; CI, confidence interval. 
4. Discussion 
In this study, we analyzed more than three million single laboratory tests ordered by almost 400 
Swiss GPs during the past decade. The most frequently requested test types were CBC, CRP, and 
renal function tests. Overall, the among-GP median testing rate amounted to 20% of consultations, 
but odds spanned over a four-fold ratio between low- and high-frequency testing GPs. Time trend 
analysis showed an increase of testing rates in two thirds of the included test types, especially vitamin 
D and HbA1c, which were subject to an almost two-fold increase over the past decade. Laboratory 
test types ranking high simultaneously in temporal increase and in between-GP variation were CRP, 
HbA1c, and vitamin B12. 
We found increasing testing frequencies for most of the test types included in our study. 
Interestingly, our results mirrored findings from a comparable analysis by O’Sullivan et al. based on 
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data from UK general practice gathered between the years 2000 and 2015 [4]. In both studies, there 
was an increase in requests of HbA1c, vitamin D, liver function tests, vitamin B12, CRP, ferritin, and 
thyroid function tests. 
Vitamin D and HbA1c testing rates, however, almost doubled within the past decade and the 
extent of their increase sets them apart from other test types. Increases and potential overuse of 
vitamin D and HbA1c tests have been identified in other healthcare settings as well. The rise in HbA1c 
testing might be linked to its adoption for diagnosis of type 2 diabetes replacing blood glucose testing 
[21]. While we see no similarly compelling explanation for the increase of vitamin D testing, it has 
been speculated that intense media and individual interest might play a substantial role [22]. Still 
poorly understood, these trends are suspected to contribute to wasteful healthcare and to increase 
patient burden without introducing adequate benefits [22–26]. Increases in testing rates of CRP, 
ferritin, vitamin B12, electrolytes, and creatinine were also notable, but less pronounced. 
Variation in laboratory testing was moderate on the level of overall testing. Most of the specific 
test types, however, were subject to variation exceeding an ICC of 0.05, which is unusual for measures 
in general practice [27]. Test types that were both associated with temporal increase and substantial 
variation between GPs were CRP, vitamin B12, HbA1c, and vitamin D. These test types are therefore 
most suspect for potential emerging overuse in Swiss general practice. Similar studies identified 
vitamin D and CRP as frequently ordered test types with relatively high between-physician variation 
in general practice, thereby also pointing at their potential overuse [28,29]. 
We used demographic variables primarily to adjust time trends, which was necessary to account 
for age and sex differences in individual GPs’ patient populations. However, several associations 
appeared and merit discussion. Increasing patient age was associated with higher requesting 
frequencies of most test types. This was unsurprising, as conditions requiring laboratory testing 
accumulate with increasing age [30]. Sex differences are, however, harder to interpret. Generally, we 
found that female patients received more laboratory testing compared to male patients, a result 
consistent with previous studies that found greater healthcare seeking behavior of female versus 
male patients in general practice [31,32]. Male sex, on the other hand, was associated with testing 
involved in cardiovascular risk estimation (lipid profile, HbA1c, fasting glucose). This may mirror 
the earlier manifestation of cardiovascular disease in in male patients [33]. However, this gender gap 
is closing [34] and, in addition, GPs are known to underestimate cardiovascular risks in female 
patients and tend to withhold preventative services to them [35]. Therefore, the sex difference we 
found may partly be a manifestation of an unwarranted gender gap. Female sex, on the other hand, 
was clearly associated with testing for vitamin D, ferritin, thyroid-stimulating hormone (TSH), and 
vitamin B12. Given the higher prevalence of osteoporosis [36], iron deficiency [37], and thyroid 
disorders [38] in female patients, our findings are concordant with epidemiologic disease 
distribution. The higher testing rate of vitamin B12 in female patients is less obvious to understand 
and may be linked to anemia investigations being more frequent in female patients due to iron 
deficiency and, in addition, to female sex being associated with vegetarian or vegan diet requiring 
vitamin B12 monitoring [39]. These factors, however, do not explain the high between-GP variation 
in vitamin B12 testing rates. 
4.1. Stengths and Limitations 
A major strength of this study is its comprehensiveness in including 89% of single laboratory 
tests requested by GPs in a large and representative database from Swiss general practice. Trends, 
associations, and between-GP variation seem plausible and closely match results from comparable 
studies in the UK, adding to external validity of our research [4,29]. Lastly, to our best knowledge, 
this study is the first exploring between-GP variation of using different laboratory test types. 
Our study presents several limitations. Firstly, we excluded rarely requested laboratory test 
types (those with <1% median among-physician sLTR) because they would have led to overdispersion 
and small sample sizes that would have been difficult to manage statistically and to interpret 
meaningfully. Secondly, younger GPs employed in urban and sub-urban areas are slightly over-
represented in the FIRE database compared to national census [40]. Thirdly, the knowledge base in the 
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domain of between-GP variation of laboratory use is scarce and we are unaware of other studies 
using ICCs for comparisons. Therefore, we must remain conservative with our interpretations of 
what constitutes unwarranted variation. On the other hand, however, our study contributes ICCs, 
which are notoriously difficult to estimate in advance, but are needed for planning potential future 
cluster-randomized trials aiming to reduce overuse of laboratory testing [27]. Lastly, this study was 
based on routine data collected from hundreds of GPs using different electronic medical records and 
export software. This made analysis vulnerable to mislabeled data, but we addressed this potential 
issue with due diligence and systematically double-checked plausibility of all laboratory test data in the 
database according to labels, units, and test result distributions on the level of each individual practice. 
5. Conclusions 
There is considerable between-GP variation of requesting laboratory tests, in part pointing at 
potential overuse. Laboratory test types associated with both high temporal increase and high 
between-GP variation were vitamin D, HbA1c, CRP, and vitamin B12. Our findings highlight the 
roadmap for initiatives aiming to better understand and ultimately reduce unwarranted variation 
and potential overuse of laboratory testing in general practice. 
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